Replies to post #2931 on Synergy Pharmaceuticals Inc fka SGYPQ

[iandy]

There is a new piece on Seeking Alpha titled: Your Daily Pharma Scoop: Soliris New Indication, Gilead's NASH Data, What Keeps Synergy Down?

The author mentions the lack of a meaningful DTC campaign and the fact Linzess has one of the best.
He also mentions the screw up with Express Scripts.

He fails to mention the prior dilution, the innane go it alone mentality, and the huge hold the shorts have on the stock.

The fundamentals are fair to ok. The technicals suck.
The only way this stock can get out of it own way is improving fundamentals.
That will happen naturally with the next approval but for the stock to really take off they have to partner, sell, or do a much better job marketing Trulance.

https://www.google.com/amp/s/seekingalpha.com/amp/article/4116244-daily-pharma-scoop-soliris-new-indication-gileads-nash-data-keeps-synergy